D-0748-2020 Class II Terminated

Recalled by Assurance Infusion — Houston, TX

FDA drug recall D-0748-2020 was initiated by Assurance Infusion on December 20, 2019 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated October 27, 2021). Affected quantity: 5 vials.

Recall Details

Product Type
Drugs
Report Date
January 22, 2020
Initiation Date
December 20, 2019
Termination Date
October 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 vials

Product Description

IPAMORELIN 2000MCG/ML INJ in 2 mL vial Assurance Infusion (713) 533-8800

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide within the United States

Code Information

Lots: 07162019@20 Exp. 01/12/2020; 12102019@17 Exp. 06/07/2020; 07162019@20 Exp. 01/12/2020